InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.84
(
-0.35%
)
Bitcoin
64,218.09
(
0.34%
)
Post# of 29294
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 10028

Wednesday, 07/22/2015 9:21:31 AM

Wednesday, July 22, 2015 9:21:31 AM

Post# of 29294
ABT’s 2Q15 sales increased 11% YoY in constant currency:

http://finance.yahoo.com/news/abbott-reports-second-quarter-2015-114500465.html

Sales of branded-generic drugs in emerging markets—including China—increased 46% YoY to $977M in constant currency; excluding acquisitions, sales of branded generics in emerging markets increased YoY at a low double-digit rate.

ABT retained 2015 non-GAAP EPS guidance of $2.10-2.20.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up